{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:15:06Z","timestamp":1790946906111,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jacep.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:14:40Z","timestamp":1734534880000},"page":"270-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["International Multicenter Cohort Study on Beta-Blocker\u2013Free Treatment Strategies for Catecholaminergic Polymorphic Ventricular Tachycardia Patients"],"prefix":"10.1016","volume":"11","author":[{"given":"Raquel","family":"Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahej","family":"Bains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Martijn","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auke T.","family":"Bergeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-164X","authenticated-orcid":false,"given":"Puck","family":"Peltenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico A.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhayan","family":"Sanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Swan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince J.","family":"Kannankeril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Brugada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Robyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-8973","authenticated-orcid":false,"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke A.E.","family":"Kammeraad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-1586","authenticated-orcid":false,"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2024.10.005_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2022.03.1225","article-title":"expert consensus statement on the state of genetic testing for cardiac diseases","volume":"19","author":"Wilde","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.10.005_bib2","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"European Heart Journal"},{"key":"10.1016\/j.jacep.2024.10.005_bib3","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/eurheartj\/ehac134","article-title":"Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias","volume":"43","author":"Schwartz","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.10.005_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2015.09.029","article-title":"Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with \u03b21-selective \u03b2-blockers in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Leren","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.10.005_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","article-title":"An international multicenter cohort study on \u03b2-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"145","author":"Peltenburg","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.10.005_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae044","article-title":"Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"26","author":"Peltenburg","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2024.10.005_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008830","article-title":"Left cardiac sympathetic denervation monotherapy in patients with congenital long QT syndrome","volume":"13","author":"Niaz","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2024.10.005_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tcm.2022.06.006","article-title":"Precision therapy in congenital long QT syndrome","volume":"34","author":"Neves","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacep.2024.10.005_bib9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.hrthm.2020.02.017","article-title":"Intentional nontherapy in long QT syndrome","volume":"17","author":"MacIntyre","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.10.005_bib10","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.10.005_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacep.2024.10.005_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-020-0188-7","article-title":"Inherited cardiac arrhythmias","volume":"6","author":"Schwartz","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jacep.2024.10.005_bib13","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2018.01.030","article-title":"Cardiac Genetic Predisposition in Sudden Infant Death Syndrome","volume":"71","author":"Tester","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.10.005_bib14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.hrthm.2007.02.026","article-title":"A\u00a0mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors","volume":"4","author":"Tester","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.10.005_bib15","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.15420\/aer.2022.09","article-title":"Catecholaminergic polymorphic ventricular tachycardia","volume":"11","author":"Abbas","year":"2022","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.jacep.2024.10.005_bib16","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.hrthm.2022.06.008","article-title":"Spectrum and prevalence of side effects and complications with guideline-directed therapies for congenital long QT syndrome","volume":"19","author":"Martinez","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.10.005_bib17","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.10.005_bib18","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.10.005_bib19","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.123.064786","article-title":"Flecainide is associated with a lower incidence of arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"148","author":"Bergeman","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.10.005_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0735-1097(02)01946-0","article-title":"Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers","volume":"40","author":"Bauce","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.10.005_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives","volume":"5","author":"van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2024.10.005_bib22","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.10.005_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.hrthm.2012.12.035","article-title":"Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia","volume":"10","author":"Watanabe","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.10.005_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hrthm.2015.09.027","article-title":"Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of \u03b2-blockade","volume":"13","author":"Padfield","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.10.005_bib25","article-title":"Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: a systematic review and meta-analysis","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacep.2024.10.005_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCEP.112.971754","article-title":"Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation\/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome","volume":"5","author":"Coleman","year":"2012","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2024.10.005_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacep.2016.01.020","article-title":"Competitive Sports participation in patients with catecholaminergic polymorphic ventricular tachycardia: a single center's early experience","volume":"2","author":"Ostby","year":"2016","journal-title":"JACC Clin Electrophysiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24008697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24008697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T01:56:16Z","timestamp":1769910976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24008697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2405500X24008697"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.10.005","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Multicenter Cohort Study on Beta-Blocker\u2013Free Treatment Strategies for Catecholaminergic Polymorphic Ventricular Tachycardia Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}